Selumetinib, Advanced Uveal Melanoma Drug, Shows Success In Clinical Trial
The team wants to combine Mekinist with an experimental Glaxo treatment that blocks a different protein called Akt based
selumetinib advanced uveal melanoma drug show success clinical trial team want combine mekinist experimental glaxo treatment block different protein call akt base